BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23374519)

  • 21. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics technology and therapeutics.
    Hong ML; Jiang N; Gopinath S; Chew FT
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):563-8. PubMed ID: 16700895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Employment of complementary dissociation techniques for body fluid characterization and biomarker discovery.
    Good DM; Rutishauser D
    Methods Mol Biol; 2013; 1002():223-32. PubMed ID: 23625407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
    Henry M; Meleady P
    Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of tissue-specific proteins into coronary perfusate as a model for biomarker discovery in myocardial ischemia/reperfusion injury.
    Cordwell SJ; Edwards AV; Liddy KA; Moshkanbaryans L; Solis N; Parker BL; Yong AS; Wong C; Kritharides L; Hambly BD; White MY
    J Proteome Res; 2012 Apr; 11(4):2114-26. PubMed ID: 22250753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis.
    Ametzazurra A; Matorras R; García-Velasco JA; Prieto B; Simón L; Martínez A; Nagore D
    Hum Reprod; 2009 Apr; 24(4):954-65. PubMed ID: 19095664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness.
    Csősz É; Kalló G; Márkus B; Deák E; Csutak A; Tőzsér J
    J Proteomics; 2017 Feb; 153():30-43. PubMed ID: 27542507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of proteomics to neurological diseases].
    Brea D; Cristobo I; Sobrino T; Rodríguez-González R; Mosquera E; Moldes O; Castillo J
    Neurologia; 2007 Apr; 22(3):170-9. PubMed ID: 17364255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Bergquist J; Palmblad M; Wetterhall M; Håkansson P; Markides KE
    Mass Spectrom Rev; 2002; 21(1):2-15. PubMed ID: 12210611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF; Haab BB; Hanash SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.
    Kolch W; Neusüss C; Pelzing M; Mischak H
    Mass Spectrom Rev; 2005; 24(6):959-77. PubMed ID: 15747373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic strategies in the search of new biomarkers in atherothrombosis.
    Tuñón J; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; López JA; Egido J
    J Am Coll Cardiol; 2010 May; 55(19):2009-16. PubMed ID: 20447523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The birth and infancy of proteomic analysis in osteoarthritis research.
    De Ceuninck F
    Curr Opin Mol Ther; 2007 Jun; 9(3):263-9. PubMed ID: 17608025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A biochemical study on the level of proteins and their percentage of nitration in the hair and nail of autistic children.
    Lakshmi Priya MD; Geetha A
    Clin Chim Acta; 2011 May; 412(11-12):1036-42. PubMed ID: 21338594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proteomic analysis of protein profiles in some pathological stages of the human organism].
    Kossowska B; Dudka I; Gancarz R; Antonowicz-Juchniewicz J
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():549-63. PubMed ID: 19940332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.
    Han NY; Kim EH; Choi J; Lee H; Hahm KB
    J Dig Dis; 2012 Oct; 13(10):497-503. PubMed ID: 22988922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
    Kischel P; Waltregny D; Castronovo V
    Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.